OğulA., & BüyükşimşekM. (2020). Prognostic role of inflammatory markers in hepatocellular cancer patients receiving sorafenib therapy. Medical Science and Discovery, 7(5), 475-481. https://doi.org/10.36472/msd.v7i5.374